Sawai K, Miyao T, Takakura Y, Hashida M
Department of Drug Delivery Research, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Antisense Res Dev. 1995 Winter;5(4):279-87. doi: 10.1089/ard.1995.5.279.
To clarify the renal disposition characteristics of oligonucleotides at the organ level, the renal handling of model end-capped oligonucleotides, 3'-methoxyethylamine 5'-biotin-decathymidylic acid containing phosphoramidate modifications at 3'- and 5'-terminal internucleoside linkages (T10) and its phosphorothioate (Ts10), were studied in the perfused rat kidney. In a single-pass indicator dilution experiment, venous outflow and urinary excretion patterns and tissue accumulation of radiolabeled oligonucleotides were evaluated under filtering or nonfiltering conditions. No significant binding to bovine serum albumin (BSA) in the perfusate was observed for T10, whereas more than 90% of Ts10 bound to BSA. The steady-state distribution volume of T10 calculated from the venous outflow pattern was larger than that of inulin, which corresponds to the extracellular volume of the kidney, whereas the distribution volume of Ts10 was larger than that of BSA (the intravascular volume). These results suggested their interaction with the vascular wall. Rapid urinary excretion was observed for T10, similar to inulin used as a marker of golmerular filtration rate. On the other hand, urinary excretion of Ts10 was greatly restricted due to its high binding ability (> 90%) to BSA in the perfusate. A significant amount of T10 and Ts10 was accumulated in the kidney (T10, 1.8% of injected dose; Ts10, 1.3%) compared with inulin (0.2%) and BSA (< 0.1%). The accumulation of these oligonucleotides was ascribed to both tubular reabsorption and uptake from the capillary side. In addition, the uptake of T10 from the capillary side was significantly inhibited by simultaneous injection of dextran sulfate, suggesting that the oligonucleotide was taken up as an anionic molecule. These findings will be useful information for the development of delivery systems for antisense oligonucleotides.
为了在器官水平上阐明寡核苷酸的肾脏处置特征,在灌注大鼠肾脏中研究了模型封端寡核苷酸、在3'-和5'-末端核苷间连接处以氨基磷酸酯修饰的3'-甲氧基乙胺5'-生物素-十聚胸苷酸(T10)及其硫代磷酸酯(Ts10)的肾脏处理情况。在单通道指示剂稀释实验中,在过滤或非过滤条件下评估了放射性标记寡核苷酸的静脉流出和尿排泄模式以及组织蓄积情况。未观察到T10与灌注液中的牛血清白蛋白(BSA)有明显结合,而超过90%的Ts10与BSA结合。根据静脉流出模式计算的T10稳态分布容积大于菊粉(对应于肾脏细胞外容积)的分布容积,而Ts10的分布容积大于BSA(血管内容积)的分布容积。这些结果表明它们与血管壁有相互作用。观察到T10的尿排泄迅速,类似于用作肾小球滤过率标志物的菊粉。另一方面,Ts10的尿排泄由于其与灌注液中BSA的高结合能力(>90%)而受到极大限制。与菊粉(0.2%)和BSA(<0.1%)相比,大量的T10和Ts10蓄积在肾脏中(T10,注射剂量的1.8%;Ts10,1.3%)。这些寡核苷酸的蓄积归因于肾小管重吸收和从毛细血管侧的摄取。此外,同时注射硫酸葡聚糖可显著抑制T10从毛细血管侧的摄取,表明该寡核苷酸作为阴离子分子被摄取。这些发现将为反义寡核苷酸递送系统的开发提供有用信息。